Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Polomar Health Services (PMHS) EBIT (2022 - 2025)

Polomar Health Services has reported EBIT over the past 4 years, most recently at -$628808.0 for Q3 2025.

  • For Q3 2025, EBIT fell 142.62% year-over-year to -$628808.0; the TTM value through Sep 2025 reached -$2.3 million, down 225.8%, while the annual FY2024 figure was -$1.3 million, 194.78% down from the prior year.
  • EBIT for Q3 2025 was -$628808.0 at Polomar Health Services, down from -$563333.0 in the prior quarter.
  • Over five years, EBIT peaked at -$13518.0 in Q3 2022 and troughed at -$689112.0 in Q4 2024.
  • A 4-year average of -$249730.4 and a median of -$156222.5 in 2022 define the central range for EBIT.
  • On a YoY basis, EBIT climbed as much as 37.8% in 2023 and fell as far as 896.29% in 2023.
  • Year by year, EBIT stood at -$151977.0 in 2022, then skyrocketed by 37.8% to -$94537.0 in 2023, then tumbled by 628.93% to -$689112.0 in 2024, then increased by 8.75% to -$628808.0 in 2025.
  • Business Quant data shows EBIT for PMHS at -$628808.0 in Q3 2025, -$563333.0 in Q2 2025, and -$415408.0 in Q1 2025.